Agbiotech spin-off receives $2.3 million

Guest Contributor
August 30, 2002

A new Univ of Alberta spin-off has received $2.3 million in venture capital from AVAC Ltd, Calgary and Foragen Technologies Management Inc, Saskatoon. Ceven Bioproducts Inc was created to commercialize new grain fractionation technology developed at the U of A by Dr Feral Temelli and Dr Thava Vasanthan. The technology when applied to cereal grains yields high-value components such as beta-glucan, a dietary fibre and an ingredient in food and health products currently limited by its high cost of production. Research on the fractionation technology was supported by the Alberta Agricultural Research Institute and Alberta Barley Commission. AVAC is a not-for-profit private firm investing in value-added agricultural commodities and Foragen is a private seed capital and management firm….


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.